MINI REVIEW article
New Vision for Visual Prostheses
- 1Department of Biomedical Engineering, College of Engineering, Michigan State University, East Lansing, MI, United States
- 2Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States
- 3Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI, United States
Developments of new strategies to restore vision and improving on current strategies by harnessing new advancements in material and electrical sciences, and biological and genetic-based technologies are of upmost health priorities around the world. Federal and private entities are spending billions of dollars on visual prosthetics technologies. This review describes the most current and state-of-the-art bioengineering technologies to restore vision. This includes a thorough description of traditional electrode-based visual prosthetics that have improved substantially since early prototypes. Recent advances in molecular and synthetic biology have transformed vision-assisted technologies; For example, optogenetic technologies that introduce light-responsive proteins offer excellent resolution but cortical applications are restricted by fiber implantation and tissue damage. Other stimulation modalities, such as magnetic fields, have been explored to achieve non-invasive neuromodulation. Miniature magnetic coils are currently being developed to activate select groups of neurons. Magnetically-responsive nanoparticles or exogenous proteins can significantly enhance the coupling between external electromagnetic devices and any neurons affiliated with these modifications. The need to minimize cytotoxic effects for nanoparticle-based therapies will likely restrict the number of usable materials. Nevertheless, advances in identifying and utilizing proteins that respond to magnetic fields may lead to non-invasive, cell-specific stimulation and may overcome many of the limitations that currently exist with other methods. Finally, sensory substitution systems also serve as viable visual prostheses by converting visual input to auditory and somatosensory stimuli. This review also discusses major challenges in the field and offers bioengineering strategies to overcome those.
The development of bioelectrical interfaces in the 18th century enthralled scientists looking for strategies to treat brain pathologies and restore vision. Revolutionary experiments by LeRoy (1755) and Volta in 1800 (Volta and Banks, 1800) succeeded in demonstrating that electrical stimulation of the eye could produce spots of light, or phosphenes, in one’s visual field.
Since then, advancements in neuroimaging, electrophysiology hardware, and surgical equipment have spurred ground-breaking research uncovering intricacies of visual pathways and possible therapeutic targets. Visual prostheses allowing for the restoration of basic abilities promoting object discrimination (Stingl et al., 2013) and simple mobility (Humayun et al., 2012), are now viable therapeutic considerations for visually impaired and blind individuals. A few retinal-based prosthetic devices have already been approved for commercial use in Europe (Humayun et al., 2012; Hornig et al., 2017), one of which is also approved in the United States (Luo and Da Cruz, 2016).
This review describes state-of-the-art electrode-based visual prostheses technologies, and the ongoing development of cutting-edge biological- and genetic-based technologies to restore visual function including nanoparticles, optogenetics, magnetic manipulation and sensory substitution systems. These methods have the capability of artificially encoding sensation i.e. “writing,” into the brain and are gaining considerable interest as next-generation visual therapeutics.
In 2015, there were 253 million individuals (3.43% of global population) blind and moderately-to-severely visually impaired people in the world (Bourne et al., 2017). By 2050, owing to a dramatic increase in life expectancy, it is predicted that this number will rise to 703 million (7.19% of global population) (Bourne et al., 2017). Blindness is the most feared condition by the American public, more so than Alzheimer’s disease, cancer and HIV/AIDS (Scott et al., 2016). Visual deficits are strongly associated with economic (Wittenborn et al., 2013), physical (McLean et al., 2014; Crews, 2016), and emotional (Stelmack, 2001; Hassell et al., 2006) detriments. While population aging is still in its early stages, large-scale communities and nations are already being challenged by the increased medical and fiscal responsibilities associated with visual impairments (Gordois et al., 2012; Wittenborn et al., 2013). In fact, the majority of public health specialists have underestimated the rapidity of this epidemiological transition and the associated need for resource reallocation (World Health Organization, 2006). Thus, it is necessary to identify new interventions to address the steep increase of visual deficits among the world population.
Electrode-Based Visual Prostheses
The traditional electrode-based visual prostheses consists of a basic set of components. A video camera is often used to convert light into electrical signals. These analog signals are digitized, and the image is processed by a portable micro-computer. The signals are then wirelessly transmitted to internal componentry with accompanying multi-electrode arrays (MEAs), which directly interface with the neural tissue.
The type of the electrode-based prostheses is dictated by the underlying pathophysiology and its location should target a region along the visual pathway that would be the most effective in restoring visual perception. Interfacing too early along the visual pathway could lead to either non-transmitted or significantly corrupted and unintelligible signals. Interfacing at a region later than necessary bypasses functional neuronal circuitry, requiring additional hardware and/or complex image-processing algorithms. There are four major prosthetic design-types, each of which are categorized based on the location of their associated MEAs. Table 1 summarizes the advantages and limitations of the different visual prostheses and their location.
Table 1. Advantages and limitations of different visual prostheses modalities with feasible interface locations.
Retinal prostheses offer promising rehabilitative potential for a number of retinal-based pathologies, including retinitis pigmentosa and age-related macular degeneration. In 1956, Tassicker developed and implanted the first retinal prostheses, capable of providing the recipient with crude light perception (Tassicker, 1956). Nearly 40 years later, Humayun et al. demonstrated that focal electrical excitation of the retinal surface could elicit cortical responses in animal models (Humayun et al., 1994) and localized visual percepts in human patients (Humayun et al., 1996). These preliminary experiments paved the way for retinal implants as the most common visual prostheses due to the orderly retinotopic organization, ease of surgical accessibility, and early positioning in the visual pathway. Two retinal prostheses sub-types, subretinal and epiretinal, constitute the majority of retinal prostheses-based research.
In the fovea, the most visually acute portion of the retina, there are an average of 150,000 (Shroff, 2011) and a peak density of 200,000 cone photoreceptors per mm2 (Curcio et al., 1990). The diameters of cone outer segments and retinal ganglion cells are 3–5 μm and 6–13 μm, respectively (Hebel and Holländer, 1983; Shepherd, 2003). Although improvements in micromachining and lithography now allow for the development of precise electrode arrays, targeting each neuron independently to reproduce natural vision is still challenging. Fortunately, extrapolating from cochlear implant patients, functional vision restoration most likely requires a total electrode count that is a mere fraction of the number of retinal neurons. Moreover, patients have been observed to demonstrate a significant learning effect and task-based improvements shortly after implantation.
Retinal-based diseases are characterized by photoreceptor cell death that glasses and contact lenses, which only refocus light rays through the cornea and lens, cannot address. Subretinal prostheses allow for the earliest possible intervention in the visual process. The prostheses most often consists of metallic electrode contacts embedded in a biocompatible polymeric film. It is positioned within the largely degenerated photoreceptor layer and directly interface with retinal bipolar cells. Since they interact with outer-retinal tissue, subretinal prostheses retain substantial intra-retinal signal processing. This allows for the generation of more naturalistic phosphenes, serving to expedite patient training periods relative to other types of visual prostheses.
Some subretinal implants even do away with the need for an external imager altogether via the use of microphotodiode arrays (MPDAs). Early research has shown that photodiodes reliant solely on ambient light can induce neurotrophic effects, but are insufficient for phosphene generation (Chow et al., 2004; Palanker et al., 2005). By incorporating circuitry for signal amplification, significant responses were seen in animal models (Lorach et al., 2015; Prévot et al., 2019) and patients can perceive distinct phosphenes (Zrenner et al., 2010; Lorach et al., 2015). Since the image is based on incident light entering the eye instead of an externally located camera for MPDAs with electronic amplification, patients can utilize natural eye movements. This is a marked advantage over camera-based visual prostheses, which are restricted to head movements for environmental scanning. Moreover, these MPDAs preserve the functionality of microsaccadic eye movements that prevent image fading by moving stimuli into and out of adjacent neurons’ receptive fields. The resultant spatial and temporal signal summation may result in more intelligible and naturalistic percepts; patients with photosensitive implants are capable of immediately recognizing shapes without any image processing (Stingl et al., 2013). A 1500 pixel MPDA subretinal implant offers visual acuity restoration up to 20/546 (Stingl et al., 2013), roughly translating to such real-world abilities as identification of office supplies and distinguishing between kitchen cutlery (Stingl et al., 2012). Some patients are even able to differentiate between large alphabet letters and combine them into words (Zrenner et al., 2010; Stingl et al., 2013). A recent study incorporated a 378-pixel array, achieving the highest visual acuity to date: 20/460. Additional testing of letter recognition and reading has already shown promising preliminary results (Palanker et al., 2019). Since MPDAs rely upon light transmittal through the cornea and lens, those with conditions that obscure light passage would not be eligible for such implants.
Research into subretinal implants has proven some initial physiological limitations, though researchers are actively seeking innovative solutions. The uneven photoreceptor density within the retina presents a major challenge. Since the density of cone photoreceptors decreases with increasing retinal eccentricity, uniform phosphene generation throughout the visual field would require MEAs with varying electrode diameters and inter-electrode spacing. Novel MEA designs that promote glial and neuronal migration may allow for lower stimulation levels and more densely packed arrays (Butterwick et al., 2009; Spira and Hai, 2013). Due to the variable thickness (Shroff, 2011) and fragility (Colodetti et al., 2007) of the degenerating retina, such designs are also surgically preferable to mitigate device-tissue contact. This prosthetic design has rehabilitative potential for millions of blind and visually-impaired individuals suffering from outer-retinal pathologies.
Epiretinal prostheses interact with retinal ganglion cells. Owing to their downstream placement, epiretinal prostheses have a wider therapeutic potential than subretinal prostheses. Since extended periods of no photoreceptor input may cause signal corruption and intra-retinal neuronal degeneration, epiretinal prostheses may be the preferred visual prostheses for mid-to-late stage outer retinal pathologies. Epiretinal arrays can even selectively stimulate ganglion cells or bipolar cells based on stimulation parameters, including pulse polarity and duration (Boinagrov et al., 2014). Optimization of these features can reduce functional threshold levels, thus allowing for smaller electrode-diameters and denser MEAs before surpassing physiological safety limits. The implants are located adjacent to the spacious vitreous humor. This allows for larger electrical componentry and mitigates electrically-induced heat absorption by nearby tissue. However, unlike subretinal MEAs that are held in place by the underlying retinal pigment epithelium, the positioning of epiretinal arrays requires scleral-retinal tacks to achieve long-term perceptual consistency. Stabilization by an individual tack induces localized damage at the tack site and can physically separate distal regions of the array from the tissue surface (Majji et al., 1999; Mahadevappa et al., 2005). Currently there is an FDA-approved retinal prostheses (Luo and Da Cruz, 2016) which consists of a 60-electrode epiretinal device that has yielded patient improvements in spatial motor tasks (Ahuja et al., 2011), motion detection (da Cruz et al., 2016), and letter-reading performance (Da Cruz et al., 2013).
Optic nerve prostheses can be efficacious for patients exhibiting retinal-based diseases or retinal detachment. Borrowing from peripheral-nerve stimulation technology (Mortimer et al., 1995), self-sizing cuff electrodes with four equidistant 200 μm2 contacts have been implanted around the optic nerve of a human patient (Veraart et al., 1998). By varying stimulation parameters, such as pulse duration and pulse train frequency optic nerve prostheses can elicit phosphene clusters of different sizes and in various locations (Veraart et al., 2003; Brelén et al., 2005). Although selective phosphene generation is rather crude, an implanted patient successfully localized, discriminated between and grasped small specific objects (Duret et al., 2006). Moreover, optic nerve prostheses benefit from enhanced electrode-phosphene efficiency and reduced tissue damage unlike high-density arrays. Such prostheses, however, are restricted to serial stimulation (Brelén et al., 2005) and lack adjustable phosphene luminosity (Delbeke et al., 2003), a feature positively correlated with performance scores on object discrimination tasks. The surface-based electrode contacts also increase current injection thresholds and reduce nerve fiber selectivity – the 1.2 million, 1-μm diameter optic nerve fibers already makes targeting specific points in the visual field extremely challenging (Jonas et al., 1992). In an effort to enhance fiber selectivity, penetrating electrode arrays have been inserted into the optic nerve. These MEAs can elicit cortical responses in animal models (Chai et al., 2008; Li et al., 2008; Lu et al., 2013; Gaillet et al., 2019) and one penetrating array, with wire electrodes progressing through the optic disk and into the optic nerve, has been implanted in a human patient (Sakaguchi et al., 2009). Similar to retinal prostheses, optic nerve prostheses, both surface-based and penetrating, benefit from a relatively less invasive intraocular surgery.
Lateral Geniculate Nucleus (LGN)
At the optic chiasm, optic nerve fibers associated with the nasal half of each retina decussate and project to contralateral subcortical structures. Ninety percent of the retinal ganglion axons synapse at the dorsal lateral geniculate nucleus (LGN) of the thalamus (Kandel et al., 2000). An LGN prostheses has rehabilitative potential for individuals with either retinal or optic nerve pathologies.
Unlike the retina, LGN receptive fields have a consistent spatial density regardless of their visual field eccentricity. Since 60% of the LGN volume is devoted to processing the central 3° of the visual field (Schneider et al., 2004), lower-density MEAs could be used, reducing tissue damage due to mechanical insertion or electrical current delivery. Thalamic visual prostheses would require numerous electrodes to generate discrete phosphenes. One proposed method to facilitate high-density MEA uses a microwire bundle inserted via a cannula (Pezaris and Eskandar, 2009). Once the electrode nears the LGN, the microwires splay outward through the end of the cannula and penetrate the tissue at distinct locations. A model of bilateral 400-electrode implants is estimated to provide visual acuity up to 20/240 (Kyada et al., 2017). In order for such a device to be efficacious, electrode material, insertion speed and current injection levels must be optimized. As with retinal and optic nerve prostheses, intervention timing will be a key consideration to mitigate downstream neuronal degradation. Patients with severe glaucoma, for example, can show a significant progressive reduction in LGN size (Gupta et al., 2009). Although prostheses targeting the LGN have yet to be implanted in humans, animal models demonstrate device efficacy via cortical responses (Panetsos et al., 2011) and crude resolution via object localization tasks (Pezaris and Reid, 2007).
One of the most important features of cortical prostheses is the downstream location. This offers rehabilitative potential for blind and visually-impaired individuals for which a retinal, optic nerve or LGN visual prostheses would be ineffective (Gabel, 2016). Furthermore, cortical implants have the longest window for therapeutic intervention; instead of total neural degeneration, post-injury compensatory plasticity mechanisms recruit deafferented neurons from other cortical regions, offering the possibility of stimulation well beyond the onset of injury or disease (Sadato et al., 1996; Pietrini et al., 2004). After the LGN, the optic radiations transmit signals to layer 4 of the primary visual cortex (V1). Neurons with similar receptive fields are organized into 1 mm2 columns, which can be further subdivided into smaller columns responsive to orientation axis, color and ocular dominance. Similar to the LGN, these columns maintain a fairly consistent spatial density across the surface of V1 owing to the cortical magnification of central visual fields (Daniel and Whitteridge, 1961; Tehovnik, 1996; Dagnelie, 2011). Figure 1 illustrates the various interfaces and their location.
The subdural electrodes used in preliminary cortical visual prostheses proved capable of eliciting phosphenes but the substantial electrode-neuron distances required milliampere-range current injection levels (Brindley and Lewin, 1968; Dobelle et al., 1974, 1976). In the 1990s, penetrating intracortical electrodes were found to exhibit vastly superior spatial resolution and induce percepts with electrical currents two to three orders of magnitude less than those of surface electrodes (Bak et al., 1990; Schmidt et al., 1996).
Cortical prostheses can comfortably access central receptive fields, which are located near the surface of the occipital lobe, but face difficulty when targeting regions corresponding to peripheral fields. The interhemispheric fissure presents an anatomical barrier for stimulating roughly 85% of V1 (Trobe, 2001) and convolutions on the surface of the brain can bury receptive fields. However, since spatial representation is preserved and repeated multiple times across the visual cortex (Wandell et al., 2007), additional MEAs can be implanted in higher visual areas if receptive fields are inaccessible in lower regions (Dagnelie, 2011). Tertiary visual areas exhibit highly specific stimulus responsivity offering the potential for generating complex visual percepts. Early simulations for restoring functional vision via cortical prostheses estimate a total of at least 625 discrete phosphenes (Cha et al., 1992). In addition to electrode manufacturing, electronics for power and information transmission and processing must be developed. For example, one complementary metal-oxide-semiconductor chip can drive 473 electrodes independently (Wong et al., 2019), far more than is currently necessary for cortical-based MEAs.
The rapid advancement of microelectronic device fabrication and information processing has made cortical prostheses a viable rehabilitative option. There are several ongoing clinical trials testing the effectiveness and the risk associated with these implants (Fernández and Normann, 2017; Lowery et al., 2017; Troyk, 2017; Pouratian et al., 2019).
Next-generation pattern-recognition and deep-learning algorithms, especially those being investigated for computer vision will complement the complex response properties of visual areas in the brain. This could greatly expand cortical prostheses recipients’ capabilities, offering depth-perception, color discrimination, figure-ground discernment, and attentional modulation.
A number of organisms express light-sensitive proteins (opsins) allowing them to perform vital functions, such as phototaxis (Nagel et al., 2002; Sineshchekov et al., 2002) and energy conservation (Ernst et al., 2013). Optogenetic technologies use viral vectors to deliver genes encoding for opsins into defined tissue regions and cell populations with excellent temporal and spatial resolution (Boyden et al., 2005; Han and Boyden, 2007; Chow et al., 2010). Once the proteins are expressed, the cell can be controlled using a specific wavelength of light. Though the majority of optogenetic-based research has utilized microbial opsins, animal opsins have also been explored for vision restoration. Preclinical trials have shown that most animal opsins exhibit excellent light sensitivity but poor temporal responsivity, compared to microbial opsins (Lin et al., 2008; Cehajic-Kapetanovic et al., 2015). However, a recent study utilized an alternative animal opsin to achieve high light sensitivity and quick response kinetics, both of which are imperative for visual prostheses (Berry et al., 2019). An opsin-free approach incorporates small light-sensitive molecules, deemed photoswitches, that can be bound to specific cellular proteins, such as ion channels. The physical conformation of photoswitches can be selectively altered by exposing the molecule to different wavelengths of light, causing neuronal excitation and inhibition. Intravitreal injections of photoswitch molecules have been found capable of restoring light-sensitivity in blind animal models (Caporale et al., 2011; Polosukhina et al., 2012).
The retina has constituted the majority of optogenetic-based visual research because of its accessibility and transparent nature (Bi et al., 2006). Since there are more than 60 cell types within the retina (Masland, 2012), different classes of microbial and animal opsins can be expressed in particular cell populations. By activating and silencing individual cell types, patients can experience more naturalistic visual percepts (Bi et al., 2006; Lagali et al., 2008; Busskamp et al., 2010). Optical-based stimulation technologies, including μLED matrices (Wu et al., 2015; Khan et al., 2018) and computer-generated holography (Lutz et al., 2008; Reutsky-Gefen et al., 2013; Hernandez et al., 2016; Shemesh et al., 2017), are currently being developed to enable cellular and sub-cellular spatial resolution.
Preclinical studies have yielded promising results in non-human primates (Ivanova et al., 2010; Chaffiol et al., 2017) and clinical trials for patients with a variety of retinal-based diseases are currently underway (ClinicalTrials.gov NCT02556736, NCT03293524, and NCT03326336). Though biocompatibility concerns are minimal compared to electrode-based prostheses, clinical trials will determine if any long-term immune responses are present (Busskamp et al., 2012). A limitation of any light-based modality is its restricted penetration depth through tissue, which often requires the insertion of optical fibers. Fortunately, experiments involving non-human primates have shown that optogenetic stimulation of cortical neurons can induce visual percepts without the need to displace neural tissue (Jazayeri et al., 2012; Ju et al., 2018). Red-shifted opsins have been developed to mitigate tissue-induced light scattering as well as enable deeper stimulation and inhibition capabilities (Lin et al., 2013; Chuong et al., 2014). With the success of optogenetic-based therapies in preclinical models, it is likely that clinical trials will soon follow suit. The incorporation of these opsins may allow for the control of retinal or cortical neurons while minimizing the tissue damage characteristic of penetrating devices.
Magnetic fields pass through biological tissue with minimal reduction in field strength, making them desirable for non-invasive neurostimulation. Indeed, scientists have been experimenting with magnetically-induced phosphenes since the late 1800s (d’Arsonval, 1896).
The first transcranial magnetic stimulation (TMS) device was demonstrated in 1985 (Barker et al., 1985), and quickly became an important clinical and preclinical method for stimulating specific regions in the brain and spinal cord. TMS involves running an alternating current through a wire coil that is placed over a region of interest. Electromagnetic induction generates currents that are capable of stimulating neurons within the specific region. Since non-invasive stimulation of the brain reduces the risks encountered in surgical patients, such as hemorrhage, infection, and the overall cost of the procedure, TMS has recently gained interest for use in functional and behavioral research as well as rehabilitation research after brain injury (Ferbert et al., 1992; Celnik et al., 2009; Lu et al., 2015; Shin et al., 2018; Krishnan et al., 2019).
Cortical electromagnetic-based prostheses would benefit from superior coil-neuron proximity, permitting numerous small, low-power devices. Recent developments in the construction of micro-scale magnetic coils have the potential to increase the effectiveness and specificity of TMS. A number of micro-coils have demonstrated device efficacy in vitro (Bonmassar et al., 2012; Lee and Fried, 2016; Rizou and Prodromakis, 2018) and in vivo (Park et al., 2013; Minusa et al., 2017). While one major attraction of such devices is their non-invasive nature, device insertion can reduce coil-neuron distance, perceptual thresholds and necessary power input (Lee et al., 2016). Advancements in material sciences can accelerate the development of implantable micro-coils that are completely encased in biocompatible polymers to reduce electrically-induced tissue inflammation and glial scarring at the tissue-electrode interface. Additionally, the asymmetric current distribution permits selective activation of longitudinally-aligned axons (Bonmassar et al., 2012), adding a slight degree of specificity based on cellular orientation. One major limiting factor of micromagnetic stimulation is that conventional solenoid coils exhibit poor power efficiency and significant heat dissipation. Efforts into coil optimization may result in stronger magnetic flux densities and induced electric current at specific regions of interest (Bonmassar et al., 2014).
Nanoparticles are extensively utilized in the fields of drug delivery (Kumari et al., 2010), biosensing (Doria et al., 2012) and tissue imaging (Gilad et al., 2008). Recently, ferrite-based magnetic nanoparticles were attached selectively to ion channels. Applying a magnetic gradient generates a force on the nanoparticles that most likely induces a conformational change on the associated membrane channel. This method has demonstrated to induce changes in cellular activity in vitro upon applying an external magnetic field (Hughes et al., 2007; Tay et al., 2016).
Another method is based on magnetic hyperthermia. When exposed to an alternating field, the orientation of a nanoparticle’s magnetic domain oscillates in accordance with the applied frequency. In response to weaker magnetic fields, this causes the nanoparticle to rotate and the particle-medium friction dissipates heat. With sufficient frequency, the localized heating can induce neuronal activation or inhibition via TRPV1 (Huang et al., 2010; Stanley et al., 2012; Chen et al., 2015; Munshi et al., 2017) or TMEM16A (Munshi et al., 2018) temperature-sensitive ion channels, respectively.
Voltage-gated ion channels expressed in V1 neurons can also be targeted by magnetoelectric composite nanoparticles. These nanoparticles, consisting of a magnetostrictive core and a piezoelectric shell, exhibit significant elastic coupling and magnetoelectric output (Nan et al., 2008). The magnetostrictive material can amplify a slowly varying external magnetic field, which induces a localized electric field via the piezoelectric compound. Rodent EEG recordings suggested that magnetoelectric nanoparticles offer an efficient method of neurostimulation (Guduru et al., 2015).
Nanoparticle materials are only suitable candidates for neurostimulation if they exhibit minimal cytotoxicity; little is known about the long-term health effects of nanoparticle delivery to the brain. Additionally, the method of effectively delivering nanoparticles to the central nervous system is a significant concern. Only a fraction of intravenously-injected nanoparticles successfully reach the brain and only do so by long-term endothelial cell endocytosis or by destroying their cellular membranes (Calvo et al., 2001; Yarjanli et al., 2017). However, non-invasive intranasal delivery may expedite delivery and reduce cell damage by bypassing the blood-brain barrier, which will make it more suitable for potential clinical applications.
Genetically Encoded Magnetic Stimulation
Ongoing efforts have been dedicated to developing genetic-based neuromodulation technologies relying on magnetic changes. Magnetogenetics is a technology that allows cell, temporal, and location specific activation via magnetic fields and could evolve into a powerful non-invasive and effective technique for neurorehabilitation and vision restoration. These technologies mitigate concerns over cytotoxicity and tissue damage because no introduction of synthetic materials is required. A recent work showed the development of a construct encoding for ferritin protein subunits fused to TRPV4 receptors and its effectivity in inducing neural changes (Wheeler et al., 2016). However, neuronal response times were on the order of 20–60 s. Therefore, this approach may be effective for visual rehabilitation once allowing short responses time.
Several organisms including birds (Wiltschko and Wiltschko, 2005), fish (Quinn, 1980) and bacteria (Fassbinder et al., 1990), are known to rely on the Earth’s magnetic field for navigation and detection of prey and predators. Indeed, magnetic stimulation has been shown to trigger neural responses in the glass catfish, Kryptopterus bicirrhis (Lissmann and Machin, 1963; Struik et al., 2001). The magnetically sensitive gene has been identified and cloned, and was termed the electromagnetic-perceptive gene (EPG). In vitro and in vivo animal studies demonstrated that EPG is capable of eliciting neural responses (Krishnan et al., 2018). A number of research teams are working toward discovering the molecular structure and the signal transduction basis of this phenomenon. This will serve to expedite the optimization of stimulation parameters, including the strength and frequency of the applied magnetic field, as well as the EPG itself via artificial and targeted mutations.
Stimulation devices that convert optical information into tactile and auditory sensory inputs may offer alternative sight to individuals who are visually impaired due to stroke or brain injury (Amedi et al., 2001; Poirier et al., 2006). Tactile sensory substitution systems consisting of fingertip pin arrays that vibrated according to incoming signals from a video camera were developed in the 1960s and offered limited reading capabilities (Linvill and Bliss, 1966; Bliss et al., 1970). Other devices that stimulated the patients’ back extended such abilities to object recognition and differentiation (Bach-y-Rita et al., 1969; Collins, 1970).
The tongue is an excellent location for a sensory substitution device because it is densely innervated and coated in electrolytic saliva. With a tongue array consisting of over 100 electrode contacts, subjects significantly increased their visual acuity (Sampaio et al., 2001; Chebat et al., 2007). One drawback to positioning an electrode grid on the surface of the tongue, is that its usage would restrict normative tasks, such as conversing and eating. Stimulating gloves (Meers and Ward, 2005), headbands (Kajimoto et al., 2006), vests (Jones et al., 2006; Cancar et al., 2013), and belts (Van Erp et al., 2005) have also been explored for navigational, kinesthetic and vision reproduction purposes. The developments of methods such as electronic skin (Fu et al., 2018) will open new frontiers in tactile-based sensory substitution devices.
Other sensory substitution research has investigated auditory stimulation as a replacement for visual input. These devices use a number of translational parameters, including substituting pitch or frequency for vertical location, binaural intensity or time-scanning for horizontal position, loudness for brightness, and timbre for color (Meijer, 1992; Capelle et al., 1998; Abboud et al., 2014). While the development of visuoauditory systems initially lagged behind that of visuotactile, since its inception in the early 1990s (Meijer, 1992), such devices are now at the forefront of sensory substitution research. One reason for the popularization of visuoauditory devices is their increased absolute bandwidth over tactile devices; sighted individuals can recognize a total of 600 different tones (Capelle et al., 1998). Since blind individuals often exhibit enhanced auditory perception, it is feasible for the total number of tones to extend beyond the maximum estimated value. One limitation of these devices is that they restrict the ability to perceive auditory environmental cues, which is a highly preferred ability in blind individuals (Brewster and Brown, 2004).
The total number of visual ailments is increasing rapidly among the general population in both developed and developing nations. Preliminary electrode-based visual prostheses demonstrated that they could induce visual percepts by interfacing with various regions of the visual system but lacked the efficiency to be adopted by blind and visually-impaired individuals in their everyday lives. Contemporary electrode-based visual prostheses have improved substantially since early prototypes. These devices can restore a number of abilities, such as crude object recognition and spatial navigation, and are now becoming a viable therapeutic consideration for blind and visually-impaired individuals. However, even with advanced micromachining and surgical procedures, limited spatial resolution and unavoidable tissue damage may render future electrode-based devices wanting. Nevertheless, non-electrode-based means for neurostimulation are being pursued. Optogenetic technologies introduces light-responsive proteins that can be used to excite or inhibit neural activity. For example, optogenetic technologies that introduce light-responsive proteins offer excellent resolution but cortical applications are restricted by fiber implantation and tissue damage. Other stimulation modalities, such as magnetic fields, have been explored to achieve non-invasive neuromodulation. Miniature magnetic coils are currently being developed to activate select groups of neurons. The poor coupling efficiency between magnetic fields and biological tissue leads to increasing power requirements and reducing achievable resolution. Magnetically-responsive nanoparticles or exogenous proteins can significantly enhance the coupling between external electromagnetic devices and any neurons affiliated with these modifications. The need to minimize cytotoxic effects for nanoparticle-based therapies will likely restrict the number of usable materials. Nevertheless, advances in identifying and utilizing proteins that respond to magnetic fields may lead to non-invasive, cell-specific stimulation and may overcome many of the limitations that currently exist with other methods. Finally, sensory substitution systems also serve as viable visual prostheses by converting visual input to auditory and tactile stimuli.
AF and GP conceptualized the manuscript, drafted the manuscript, revised and finalized it, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
This work was funded by the NIH/NINDS R01NS072171 and NIH/NINDS R01NS098231.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abboud, S., Hanassy, S., Levy-Tzedek, S., Maidenbaum, S., and Amedi, A. (2014). EyeMusic: introducing a “visual” colorful experience for the blind using auditory sensory substitution. Restor. Neurol. Neurosci. 32, 247–257. doi: 10.3233/RNN-130338
Ahuja, A. K., Dorn, J., Caspi, A., McMahon, M., Dagnelie, G., Stanga, P., et al. (2011). Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br. J. Ophthalmol. 95, 539–543. doi: 10.1136/bjo.2010.179622
Bach-y-Rita, P., Kaczmarek, K. A., Tyler, M. E., and Garcia-Lara, J. (1998). Form perception with a 49-point electrotactile stimulus array on the tongue: a technical note. J. Rehabil. Res. Dev. 35, 427–430.
Baid, R., Upadhyay, A. K., Shinohara, T., and Kompella, U. B. (2013). Biosynthesis, characterization, and efficacy in retinal degenerative diseases of lens epithelium-derived growth factor fragment (LEDGF1-326), a novel therapeutic protein. J. Biol. Chem. 288, 17372–17383. doi: 10.1074/jbc.M112.441618
Bak, M., Girvin, J., Hambrecht, F., Kufta, C., Loeb, G., and Schmidt, E. (1990). Visual sensations produced by intracortical microstimulation of the human occipital cortex. Med. Biol. Eng. Comput. 28, 257–259. doi: 10.1007/bf02442682
Berry, M. H., Holt, A., Salari, A., Veit, J., Visel, M., Levitz, J., et al. (2019). Restoration of high-sensitivity and adapting vision with a cone opsin. Nat. Commun. 10:1221. doi: 10.1038/s41467-019-09124-x
Bi, A., Cui, J., Ma, Y.-P., Olshevskaya, E., Pu, M., Dizhoor, A. M., et al. (2006). Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 50, 23–33. doi: 10.1016/j.neuron.2006.02.026
Boinagrov, D., Pangratz-Fuehrer, S., Goetz, G., and Palanker, D. (2014). Selectivity of direct and network-mediated stimulation of the retinal ganglion cells with epi-, sub-and intraretinal electrodes. J. Neural Eng. 11:026008. doi: 10.1088/1741-2560/11/2/026008
Bourne, R. R., Flaxman, S. R., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., et al. (2017). Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Global Health 5, e888–e897.
Brewster, S., and Brown, L. M. (2004). “Tactons: structured tactile messages for non-visual information display,” in Proceedings of the Fifth Conference on Australasian User Interface-Volume, Vol. 28, (Darlinghurst: Australian Computer Society, Inc), 15–23.
Busskamp, V., Duebel, J., Balya, D., Fradot, M., Viney, T. J., Siegert, S., et al. (2010). Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 329, 413–417. doi: 10.1126/science.1190897
Butterwick, A., Huie, P., Jones, B., Marc, R., Marmor, M., and Palanker, D. (2009). Effect of shape and coating of a subretinal prosthesis on its integration with the retina. Exp. Eye Res. 88, 22–29. doi: 10.1016/j.exer.2008.09.018
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D’Angelo, J., Noel, J.-P., et al. (2001). Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm. Res. 18, 1157–1166.
Cancar, L., Díaz, A., Barrientos, A., Travieso, D., and Jacobs, D. M. (2013). Tactile-sight: a sensory substitution device based on distance-related vibrotactile flow. Int. J. Adv. Rob. Syst. 10:272. doi: 10.5772/56235
Capelle, C., Trullemans, C., Arno, P., and Veraart, C. (1998). A real-time experimental prototype for enhancement of vision rehabilitation using auditory substitution. IEEE Trans. Biomed. Eng. 45, 1279–1293. doi: 10.1109/10.720206
Caporale, N., Kolstad, K. D., Lee, T., Tochitsky, I., Dalkara, D., Trauner, D., et al. (2011). LiGluR restores visual responses in rodent models of inherited blindness. Mol. Ther. 19, 1212–1219. doi: 10.1038/mt.2011.103
Cehajic-Kapetanovic, J., Eleftheriou, C., Allen, A. E., Milosavljevic, N., Pienaar, A., Bedford, R., et al. (2015). Restoration of vision with ectopic expression of human rod opsin. Curr. Biol. 25, 2111–2122. doi: 10.1016/j.cub.2015.07.029
Celnik, P., Paik, N.-J., Vandermeeren, Y., Dimyan, M., and Cohen, L. G. (2009). Effects of combined peripheral nerve stimulation and brain polarization on performance of a motor sequence task after chronic stroke. Stroke 40, 1764–1771. doi: 10.1161/STROKEAHA.108.540500
Chaffiol, A., Caplette, R., Jaillard, C., Brazhnikova, E., Desrosiers, M., Dubus, E., et al. (2017). A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina. Mol. Ther. 25, 2546–2560. doi: 10.1016/j.ymthe.2017.07.011
Chow, A. Y., Chow, V. Y., Packo, K. H., Pollack, J. S., Peyman, G. A., and Schuchard, R. (2004). The artificial silicon retina microchip for the treatment of visionloss from retinitis pigmentosa. Arch. Ophthalmol. 122, 460–469.
Chow, B. Y., Han, X., Dobry, A. S., Qian, X., Chuong, A. S., Li, M., et al. (2010). High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 463:98. doi: 10.1038/nature08652
Chuong, A. S., Miri, M. L., Busskamp, V., Matthews, G. A., Acker, L. C., Sørensen, A. T., et al. (2014). Noninvasive optical inhibition with a red-shifted microbial rhodopsin. Nat. Neurosci. 17:1123. doi: 10.1038/nn.3752
Colodetti, L., Weiland, J., Colodetti, S., Ray, A., Seiler, M., Hinton, D., et al. (2007). Pathology of damaging electrical stimulation in the retina. Exp. Eye Res. 85, 23–33. doi: 10.1016/j.exer.2007.02.014
Da Cruz, L., Coley, B. F., Dorn, J., Merlini, F., Filley, E., Christopher, P., et al. (2013). The argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br. J. Ophthalmol. 97, 632–636. doi: 10.1136/bjophthalmol-2012-301525
da Cruz, L., Dorn, J. D., Humayun, M. S., Dagnelie, G., Handa, J., Barale, P.-O., et al. (2016). Five-year safety and performance results from the Argus II retinal prosthesis system clinical trial. Ophthalmology 123, 2248–2254. doi: 10.1016/j.ophtha.2016.06.049
Dobelle, W. H., Mladejovsky, M., and Girvin, J. (1974). Artificial vision for the blind: electrical stimulation of visual cortex offers hope for a functional prosthesis. Science 183, 440–444. doi: 10.1126/science.183.4123.440
Duret, F., Brelén, M. E., Lambert, V., Gérard, B., Delbeke, J., and Veraart, C. (2006). Object localization, discrimination, and grasping with the optic nerve visual prosthesis. Restor. Neurol. Neurosci. 24, 31–40.
Ernst, O. P., Lodowski, D. T., Elstner, M., Hegemann, P., Brown, L. S., and Kandori, H. (2013). Microbial and animal rhodopsins: structures, functions, and molecular mechanisms. Chem. Rev. 114, 126–163. doi: 10.1021/cr4003769
Ferbert, A., Priori, A., Rothwell, J., Day, B., Colebatch, J., and Marsden, C. (1992). Interhemispheric inhibition of the human motor cortex. J. Physiol. 453, 525–546. doi: 10.1113/jphysiol.1992.sp019243
Fu, Y., Zhang, M., Dai, Y., Zeng, H., Sun, C., Han, Y., et al. (2018). A self-powered brain multi-perception receptor for sensory-substitution application. Nano Energy 44, 43–52. doi: 10.1016/j.nanoen.2017.11.068
Gaillet, V., Cutrone, A., Artoni, F., Vagni, P., Pratiwi, A. M., Romero, S. A., et al. (2019). Spatially selective activation of the visual cortex via intraneural stimulation of the optic nerve. Nat. Biomed. Eng. 3, 1–14. doi: 10.1038/s41551-019-0446-8
Gilad, A. A., Walczak, P., McMahon, M. T., Na, H. B., Lee, J. H., An, K., et al. (2008). MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticles. Magnetic Resonance Med. 60, 1–7. doi: 10.1002/mrm.21622
Gordois, A., Cutler, H., Pezzullo, L., Gordon, K., Cruess, A., Winyard, S., et al. (2012). An estimation of the worldwide economic and health burden of visual impairment. Global Public Health 7, 465–481. doi: 10.1080/17441692.2011.634815
Gupta, N., Greenberg, G., De Tilly, L. N., Gray, B., Polemidiotis, M., and Yücel, Y. H. (2009). Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br. J. Ophthalmol. 93, 56–60. doi: 10.1136/bjo.2008.138172
Han, X., and Boyden, E. S. (2007). Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution. PloS One 2:e299. doi: 10.1371/journal.pone.0000299
Hernandez, O., Papagiakoumou, E., Tanese, D., Fidelin, K., Wyart, C., and Emiliani, V. (2016). Three-dimensional spatiotemporal focusing of holographic patterns. Nat. Commun. 7:11928. doi: 10.1038/ncomms11928
Huang, H., Delikanli, S., Zeng, H., Ferkey, D. M., and Pralle, A. (2010). Remote control of ion channels, and neurons through magnetic-field heating of nanoparticles. Nat. Nanotechnol. 5, 602–606. doi: 10.1038/nnano.2010.125
Hughes, S., McBain, S., Dobson, J., and El Haj, A. J. (2007). Selective activation of mechanosensitive ion channels using magnetic particles. J. R. Soc. Interface 5, 855–863. doi: 10.1098/rsif.2007.1274
Humayun, M. S., De Juan, E., Dagnelie, G., Greenberg, R. J., Propst, R. H., and Phillips, D. H. (1996). Visual perception elicited by electrical stimulation of retina in blind humans. Arch. Ophthalmol. 114, 40–46.
Humayun, M. S., Dorn, J. D., Da Cruz, L., Dagnelie, G., Sahel, J.-A., Stanga, P. E., et al. (2012). Interim results from the international trial of Second Sight’s visual prosthesis. Ophthalmology 119, 779–788. doi: 10.1016/j.ophtha.2011.09.028
Ivanova, E., Hwang, G.-S., Pan, Z. H., and Troilo, D. (2010). Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina. Invest. Ophthalmol. Vis. Sci. 51, 5288–5296. doi: 10.1167/iovs.10-5389
Ju, N., Jiang, R., Macknik, S. L., Martinez-Conde, S., and Tang, S. (2018). Long-term all-optical interrogation of cortical neurons in awake-behaving nonhuman primates. PLoS Biol. 16:e2005839. doi: 10.1371/journal.pbio.2005839
Krishnan, V., Park, S. A., Shin, S. S., Alon, L., Tressler, C. M., Stokes, W., et al. (2018). Wireless control of cellular function by activation of a novel protein responsive to electromagnetic fields. Sci. Rep. 8:8764. doi: 10.1038/s41598-018-27087-9
Krishnan, V. S., Shin, S. S., Belegu, V., Celnik, P., Reimers, M., Smith, K. R., et al. (2019). Multimodal evaluation of TMS-induced somatosensory plasticity and behavioral recovery in rats with contusion spinal cord injury. Front. Neurosci. 13:387. doi: 10.3389/fnins.2019.00387
Lagali, P. S., Balya, D., Awatramani, G. B., Münch, T. A., Kim, D. S., Busskamp, V., et al. (2008). Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat Neurosci. 11:667. doi: 10.1038/nn.2117
Lee, S. W., and Fried, S. I. (2016). Enhanced control of cortical pyramidal neurons with micromagnetic stimulation. IEEE Trans. Neural Syst Rehabil. Eng. 25, 1375–1386. doi: 10.1109/TNSRE.2016.2631446
Lin, B., Koizumi, A., Tanaka, N., Panda, S., and Masland, R. H. (2008). Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin. Proc. Nal Acad. Sci. U.S.A. 105, 16009–16014. doi: 10.1073/pnas.0806114105
Lin, J. Y., Knutsen, P. M., Muller, A., Kleinfeld, D., and Tsien, R. Y. (2013). ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat. Neurosci. 16:1499. doi: 10.1038/nn.3502
Lu, H., Kobilo, T., Robertson, C., Tong, S., Celnik, P., and Pelled, G. (2015). Transcranial magnetic stimulation facilitates neurorehabilitation after pediatric traumatic brain injury. Sci. Rep. 5:14769. doi: 10.1038/srep14769
Lu, Y., Yan, Y., Chai, X., Ren, Q., Chen, Y., and Li, L. (2013). Electrical stimulation with a penetrating optic nerve electrode array elicits visuotopic cortical responses in cats. J. Neural Eng. 10:036022. doi: 10.1088/1741-2560/10/3/036022
Mahadevappa, M., Weiland, J. D., Yanai, D., Fine, I., Greenberg, R. J., and Humayun, M. S. (2005). Perceptual thresholds and electrode impedance in three retinal prosthesis subjects. IEEE Trans. Neural Syst. Rehabil. Eng. 13, 201–206. doi: 10.1109/tnsre.2005.848687
Majji, A. B., Humayun, M. S., Weiland, J. D., Suzuki, S., D’Anna, S. A., and de Juan, E. (1999). Long-term histological and electrophysiological results of an inactive epiretinal electrode array implantation in dogs. Invest. Ophthalmol. Vis. Sci. 40, 2073–2081.
McLean, G., Guthrie, B., Mercer, S. W., and Smith, D. J. (2014). Visual impairment is associated with physical and mental comorbidities in older adults: a cross-sectional study. BMC Med. 12:181. doi: 10.1186/s12916-014-0181-7
Meers, S., and Ward, K. (2005). “A substitute vision system for providing 3D perception and GPS navigation via electro-tactile stimulation,” in Proceedings of the International Conference on Sensing Technology, (Palmerston North), 21–23.
Minusa, S., Osanai, H., and Tateno, T. (2017). Micromagnetic Stimulation of the Mouse Auditory CortexIn VivoUsing an Implantable Solenoid System. IEEE Trans. Biomed. Eng. 65, 1301–1310. doi: 10.1109/tbme.2017.2748136
Mortimer, T., Agnew, W. F., Horch, K., Citron, P., Creasey, G., and Kantor, C. (1995). Perspectives on new electrode technology for stimulating peripheral nerves with implantable motor prostheses. IEEE Trans. Rehabil. Eng. 3, 145–154. doi: 10.1109/86.392373
Munshi, R., Qadri, S. M., Zhang, Q., Rubio, I. C., del Pino, P., and Pralle, A. (2017). Magnetothermal genetic deep brain stimulation of motor behaviors in awake, freely moving mice. Elife 6:e27069. doi: 10.7554/eLife.27069
Nagel, G., Ollig, D., Fuhrmann, M., Kateriya, S., Musti, A. M., Bamberg, E., et al. (2002). Channelrhodopsin-1: a light-gated proton channel in green algae. Science 296, 2395–2398. doi: 10.1126/science.1072068
Nan, C. W., Bichurin, M., Dong, S., Viehland, D., and Srinivasan, G. (2008). Multiferroic magnetoelectric composites: historical perspective, status, and future directions. J. Appl. Phys. 103:1. doi: 10.2514/5.9781600866234.0001.0010
Palanker, D. V., Le Mer, Y., Hornig, R., Buc, G., Deterre, M., Bismuth, V., et al. (2019). Restoration of sight in geographic atrophy using a photovoltaic subretinal prosthesis. Invest. Ophthalmol. Vis. Sci. 60, 970–970.
Panetsos, F., Sanchez-Jimenez, A., Diaz-de Cerio, E. R., Diaz-Guemes, I., and Sanchez, F. M. (2011). Consistent phosphenes generated by electrical microstimulation of the visual thalamus. An experimental approach for thalamic visual neuroprostheses. Front. Neurosci. 5:84. doi: 10.3389/fnins.2011.00084
Park, H. J., Bonmassar, G., Kaltenbach, J. A., Machado, A. G., Manzoor, N. F., and Gale, J. T. (2013). Activation of the central nervous system induced by micro-magnetic stimulation. Nat. Commun. 4:2463. doi: 10.1038/ncomms3463
Pezaris, J. S., and Reid, R. C. (2007). Demonstration of artificial visual percepts generated through thalamic microstimulation. Proc. Natl. Acad. Sci. U.S.A. 104, 7670–7675. doi: 10.1073/pnas.0608563104
Pietrini, P., Furey, M. L., Ricciardi, E., Gobbini, M. I., Wu, W. H. C., Cohen, L., et al. (2004). Beyond sensory images: object-based representation in the human ventral pathway. Proc. Natl. Acad. Sci. U.S.A. 101, 5658–5663. doi: 10.1073/pnas.0400707101
Poirier, C., Collignon, O., Scheiber, C., Renier, L., Vanlierde, A., Tranduy, D., et al. (2006). Auditory motion perception activates visual motion areas in early blind subjects. Neuroimage 31, 279–285. doi: 10.1016/j.neuroimage.2005.11.036
Polosukhina, A., Litt, J., Tochitsky, I., Nemargut, J., Sychev, Y., De Kouchkovsky, I., et al. (2012). Photochemical restoration of visual responses in blind mice. Neuron 75, 271–282. doi: 10.1016/j.neuron.2012.05.022
Prévot, P.-H., Gehere, K., Arcizet, F., Akolkar, H., Khoei, M. A., Blaize, K., et al. (2019). Behavioural responses to a photovoltaic subretinal prosthesis implanted in non-human primates. Nat. Biomed. Eng.. doi: 10.1038/s41551-019-0484-2 [Epub ahead of print].
Reutsky-Gefen, I., Golan, L., Farah, N., Schejter, A., Tsur, L., Brosh, I., et al. (2013). Holographic optogenetic stimulation of patterned neuronal activity for vision restoration. Nat. Commun. 4:1509. doi: 10.1038/ncomms2500
Rizou, M. E., and Prodromakis, T. (2018). Magnetic stimulation in the microscale: the development of a 6 × 6 array of micro-coils for stimulation of excitable cells in vitro. Biomed. Phys. Eng. Exp. 4:025016. doi: 10.1088/2057-1976/aaa0dd
Sadato, N., Pascual-Leone, A., Grafman, J., Ibañez, V., Deiber, M.-P., Dold, G., et al. (1996). Activation of the primary visual cortex by Braille reading in blind subjects. Nature 380:526. doi: 10.1038/380526a0
Sakaguchi, H., Kamei, M., Fujikado, T., Yonezawa, E., Ozawa, M., Cecilia-Gonzalez, C., et al. (2009). Artificial vision by direct optic nerve electrode (AV-DONE) implantation in a blind patient with retinitis pigmentosa. J, Artif. Organs 12, 206–209. doi: 10.1007/s10047-009-0467-2
Schmidt, E., Bak, M., Hambrecht, F., Kufta, C., O’rourke, D., and Vallabhanath, P. (1996). Feasibility of a visual prosthesis for the blind based on intracortical micro stimulation of the visual cortex. Brain 119, 507–522. doi: 10.1093/brain/119.2.507
Schneider, K. A., Richter, M. C., and Kastner, S. (2004). Retinotopic organization and functional subdivisions of the human lateral geniculate nucleus: a high-resolution functional magnetic resonance imaging study. J. Neurosci. 24, 8975–8985. doi: 10.1523/jneurosci.2413-04.2004
Shemesh, O. A., Tanese, D., Zampini, V., Linghu, C., Piatkevich, K., Ronzitti, E., et al. (2017). Temporally precise single-cell-resolution optogenetics. Nat. Neurosci. 20:1796. doi: 10.1038/s41593-017-0018-8
Shin, S. S., Krishnan, V., Stokes, W., Robertson, C., Celnik, P., Chen, Y., et al. (2018). Transcranial magnetic stimulation and environmental enrichment enhances cortical excitability and functional outcomes after traumatic brain injury. Brain Stimul. 11, 1306–1313. doi: 10.1016/j.brs.2018.07.050
Sineshchekov, O. A., Jung, K. H., and Spudich, J. L. (2002). Two rhodopsins mediate phototaxis to low-and high-intensity light in Chlamydomonas reinhardtii. Proc. Natl. Acad. Sci. U.S.A.99, 8689–8694. doi: 10.1073/pnas.122243399
Stanley, S. A., Gagner, J. E., Damanpour, S., Yoshida, M., Dordick, J. S., and Friedman, J. M. (2012). Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 336, 604–608. doi: 10.1126/science.1216753
Stingl, K., Bartz-Schmidt, K., Besch, D., Gekeler, F., Greppmaier, U., Hörtdörfer, G., et al. (2012). What can blind patients see in daily life with the subretinal Alpha IMS implant? Current overview from the clinical trial in Tübingen. Ophthalmol 109, 136–141. doi: 10.1007/s00347-011-2479-6
Stingl, K., Bartz-Schmidt, K. U., Besch, D., Braun, A., Bruckmann, A., Gekeler, F., et al. (2013). Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc. R. Soc. BBiol Sci. 280:20130077. doi: 10.1098/rspb.2013.0077
Struik, M. L., Steenbergen, H. G., Koster, A. S., Bretschneider, F., and Peters, R. C. (2001). Simultaneous measurements of calcium mobilization and afferent nerve activity in electroreceptor organs of anesthetized Kryptopterus bicirrhis. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 130, 607–613. doi: 10.1016/s1095-6433(01)00436-6
Veraart, C., Raftopoulos, C., Mortimer, J. T., Delbeke, J., Pins, D., Michaux, G., et al. (1998). Visual sensations produced by optic nerve stimulation using an implanted self-sizing spiral cuff electrode. Brain Res. 813, 181–186. doi: 10.1016/s0006-8993(98)00977-9
Veraart, C., Wanet-Defalque, M. C., Gérard, B., Vanlierde, A., and Delbeke, J. (2003). Pattern recognition with the optic nerve visual prosthesis. Artif. Organs 27, 996–1004. doi: 10.1046/j.1525-1594.2003.07305.x
Waldvogel, D., van Gelderen, P., Muellbacher, W., Ziemann, U., Immisch, I., and Hallett, M. (2000). The relative metabolic demand of inhibition and excitation. Nature 406, 995–998. doi: 10.1038/35023171
Wheeler, M. A., Smith, C. J., Ottolini, M., Barker, B. S., Purohit, A. M., Grippo, R. M., et al. (2016). Genetically targeted magnetic control of the nervous system. Nat. Neurosci. 19:756. doi: 10.1038/nn.4265
Wittenborn, J. S., Zhang, X., Feagan, C. W., Crouse, W. L., Shrestha, S., Kemper, A. R., et al. (2013). The economic burden of vision loss and eye disorders among the United States population younger than 40 years. Ophthalmology 120, 1728–1735. doi: 10.1016/j.ophtha.2013.01.068
Wong, Y. T., Feleppa, T., Mohan, A., Browne, D., Szlawski, J., Rosenfeld, J. V., et al. (2019). CMOS stimulating chips capable of wirelessly driving 473 electrodes for a cortical vision prosthesis. J. Neural Eng. 16:026025. doi: 10.1088/1741-2552/ab021b
Wu, F., Stark, E., Ku, P.-C., Wise, K. D., Buzsáki, G., and Yoon, E. (2015). Monolithically integrated μLEDs on silicon neural probes for high-resolution optogenetic studies in behaving animals. Neuron 88, 1136–1148. doi: 10.1016/j.neuron.2015.10.032
Yarjanli, Z., Ghaedi, K., Esmaeili, A., Rahgozar, S., and Zarrabi, A. (2017). Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci. 18:51. doi: 10.1186/s12868-017-0369-9
Zrenner, E., Bartz-Schmidt, K. U., Benav, H., Besch, D., Bruckmann, A., Gabel, V.-P., et al. (2010). Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc. R. Soc. BBiol. Sci. 278, 1489–1497. doi: 10.1098/rspb.2010.1747
Keywords: vision, bioengineering, visual prostheses, neuromodulation, magnetic stimulation, cortical implant
Citation: Farnum A and Pelled G (2020) New Vision for Visual Prostheses. Front. Neurosci. 14:36. doi: 10.3389/fnins.2020.00036
Received: 14 November 2019; Accepted: 13 January 2020;
Published: 18 February 2020.
Edited by:Yael Hanein, Tel Aviv University, Israel
Reviewed by:Serge Picaud, INSERM U968 Institut de la Vision, France
Anja Kunze, Montana State University, United States
Copyright © 2020 Farnum and Pelled. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Galit Pelled, firstname.lastname@example.org